QUOTE AND NEWS
DailyFinance  Jul 19  Comment 
Separate 2014 Cease and Desist Orders Not ImpactedSAN JOSE, CA -- (Marketwired) -- 07/18/14 -- Align Technology, Inc. (NASDAQ: ALGN) today announced that the Federal Circuit reversed the final determination issued by the International Trade...
DailyFinance  Jul 18  Comment 
Separate 2014 Cease and Desist Orders Not ImpactedSAN JOSE, CA -- (Marketwired) -- 07/18/14 -- Align Technology, Inc. (NASDAQ: ALGN) today announced that the Federal Circuit reversed the final determination issued by the International Trade...
DailyFinance  Jul 7  Comment 
SAN JOSE, CA -- (Marketwired) -- 07/07/14 -- Align Technology, Inc. (NASDAQ: ALGN) announced today that the Company will report second quarter 2014 financial results on Thursday, July 24, 2014 after the close of market, not July 23, which was...
DailyFinance  Jul 1  Comment 
SAN JOSE, CA -- (Marketwired) -- 07/01/14 -- Align Technology, Inc. (NASDAQ: ALGN) announced today that the Company will report second quarter 2014 financial results on Wednesday, July 23, 2014 after the close of market. Financial results will be...
Market Intelligence Center  Jun 17  Comment 
A covered call identified by MarketIntelligececenter.com's patented algorithms on Align Technology Inc (ALGN) could yield about 7.64% (22.68% annualized, for comparison purposes only) in 123 days. Pair a long position in the stock with the Oct....
DailyFinance  Jun 3  Comment 
SAN JOSE, CA -- (Marketwired) -- 06/03/14 -- Align Technology, Inc. (NASDAQ: ALGN) Temporary stay of cease and desist orders issued on procedural grounds ITC reaffirms correctness of its Final Determination against ClearCorrect No change in ITC...
DailyFinance  May 30  Comment 
SAN JOSE, CA -- (Marketwired) -- 05/30/14 -- Align Technology, Inc. (NASDAQ: ALGN) today announced that Shirley Stacy, vice president, corporate communications and investor relations of Align Technology is scheduled to speak at the Jefferies 2014...
DailyFinance  May 19  Comment 
SAN JOSE, CA -- (Marketwired) -- 05/19/14 -- Align Technology, Inc. (NASDAQ: ALGN) today announced awards totaling $270,000 in new research funding to eight universities in North America and six international universities for projects seeking to...
Market Intelligence Center  Apr 29  Comment 
The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Align Technology Inc (ALGN) that should provide a 11.72% return in just 263 days. Sell one Jan. '15 call at the $47.00 level for...
Market Intelligence Center  Apr 28  Comment 
Align Technology Inc. (ALGN) reported adjusted earnings of 39 cents per share, up 50% from the year-ago level of 26 cents. Earnings per share also topped the Zacks Consensus Estimate of 36 cents by a wide margin. However, the 4.7% drop in share...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.


Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki